Kodiak Sciences Analyst Ratings
Kodiak Sciences Analyst Ratings
科迪亞克科學分析師評級
While ratings are subjective and will change, the latest Kodiak Sciences (KOD) rating was a downgraded with a price target of $15.00 to $4.00. The current price Kodiak Sciences (KOD) is trading at is $3.24, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/27/2023 | 23.46% | UBS | $15 → $4 | Downgrades | Buy → Neutral |
| 07/25/2023 | — | Chardan Capital | Downgrades | Buy → Neutral | |
| 07/25/2023 | -38.27% | Barclays | $5 → $2 | Maintains | Underweight |
| 07/25/2023 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 07/24/2023 | -7.41% | Jefferies | → $3 | Downgrades | Buy → Hold |
| 07/24/2023 | 116.05% | Capital One | → $7 | Downgrades | Overweight → Equal-Weight |
| 04/04/2023 | 208.64% | JP Morgan | $12 → $10 | Maintains | Neutral |
| 11/14/2022 | 177.78% | Morgan Stanley | $12 → $9 | Maintains | Equal-Weight |
| 11/10/2022 | 146.91% | Goldman Sachs | $9 → $8 | Maintains | Neutral |
| 08/15/2022 | 270.37% | Morgan Stanley | $10 → $12 | Maintains | Equal-Weight |
| 08/10/2022 | 455.56% | Chardan Capital | $19 → $18 | Maintains | Buy |
| 08/09/2022 | 362.96% | Truist Securities | $10 → $15 | Maintains | Buy |
| 08/09/2022 | 177.78% | Goldman Sachs | $5 → $9 | Maintains | Neutral |
| 08/02/2022 | 85.19% | Citigroup | → $6 | Downgrades | Neutral → Sell |
| 05/24/2022 | 54.32% | Goldman Sachs | $7 → $5 | Maintains | Neutral |
| 05/17/2022 | 208.64% | Morgan Stanley | $12 → $10 | Maintains | Equal-Weight |
| 05/11/2022 | 116.05% | Goldman Sachs | $8 → $7 | Maintains | Neutral |
| 04/12/2022 | 270.37% | Morgan Stanley | $17 → $12 | Maintains | Equal-Weight |
| 02/24/2022 | 424.69% | Morgan Stanley | $77 → $17 | Maintains | Equal-Weight |
| 02/24/2022 | 270.37% | Citigroup | $70 → $12 | Maintains | Neutral |
| 02/24/2022 | 548.15% | JP Morgan | $90 → $21 | Downgrades | Overweight → Neutral |
| 02/07/2022 | 1443.21% | Barclays | $81 → $50 | Maintains | Underweight |
| 02/02/2022 | 2677.78% | JP Morgan | → $90 | Upgrades | Neutral → Overweight |
| 02/01/2022 | 2276.54% | Morgan Stanley | $122 → $77 | Maintains | Equal-Weight |
| 01/26/2022 | 2060.49% | Citigroup | $114 → $70 | Maintains | Neutral |
| 01/18/2022 | 3665.43% | Morgan Stanley | $119 → $122 | Maintains | Equal-Weight |
| 11/11/2021 | 3418.52% | Citigroup | $103 → $114 | Maintains | Neutral |
| 05/11/2021 | 2554.32% | Barclays | $90 → $86 | Maintains | Underweight |
| 05/11/2021 | 3109.88% | BMO Capital | $138 → $104 | Maintains | Market Perform |
| 05/11/2021 | 4498.77% | Roth Capital | $155 → $149 | Upgrades | Neutral → Buy |
| 05/04/2021 | 4437.04% | Truist Securities | $89 → $147 | Maintains | Buy |
| 04/19/2021 | 3572.84% | Morgan Stanley | $133 → $119 | Maintains | Equal-Weight |
| 03/12/2021 | — | Evercore ISI Group | Initiates Coverage On | → Outperform | |
| 03/08/2021 | 4004.94% | Morgan Stanley | $125 → $133 | Maintains | Equal-Weight |
| 03/01/2021 | 2677.78% | Barclays | $52 → $90 | Downgrades | Equal-Weight → Underweight |
| 02/17/2021 | 4683.95% | Roth Capital | $133 → $155 | Downgrades | Buy → Neutral |
| 01/25/2021 | 4467.9% | BMO Capital | $145 → $148 | Downgrades | Outperform → Market Perform |
| 12/17/2020 | 4714.81% | Berenberg | → $156 | Initiates Coverage On | → Buy |
| 12/11/2020 | 4035.8% | Citigroup | → $134 | Initiates Coverage On | → Neutral |
| 11/30/2020 | 3758.02% | JP Morgan | → $125 | Downgrades | Overweight → Neutral |
| 11/16/2020 | 3758.02% | Morgan Stanley | → $125 | Downgrades | Overweight → Equal-Weight |
| 11/13/2020 | 3140.74% | Goldman Sachs | → $105 | Downgrades | Buy → Neutral |
| 11/10/2020 | 4004.94% | Roth Capital | $124 → $133 | Maintains | Buy |
| 07/28/2020 | 2646.91% | SunTrust Robinson Humphrey | $90 → $89 | Maintains | Buy |
| 05/14/2020 | 2677.78% | SunTrust Robinson Humphrey | $101 → $90 | Maintains | Buy |
| 04/15/2020 | 2369.14% | Morgan Stanley | $82 → $80 | Maintains | Overweight |
| 03/31/2020 | 2183.95% | BMO Capital | → $74 | Initiates Coverage On | → Outperform |
| 03/03/2020 | 2369.14% | Goldman Sachs | → $80 | Initiates Coverage On | → Buy |
| 02/18/2020 | 2029.63% | Barclays | → $69 | Downgrades | Overweight → Equal-Weight |
| 02/06/2020 | 3017.28% | SunTrust Robinson Humphrey | → $101 | Initiates Coverage On | → Buy |
| 01/03/2020 | 2986.42% | HC Wainwright & Co. | → $100 | Initiates Coverage On | → Buy |
| 12/24/2019 | 2430.86% | JP Morgan | → $82 | Initiates Coverage On | → Overweight |
| 12/17/2019 | 2430.86% | Morgan Stanley | $33 → $82 | Maintains | Overweight |
| 02/20/2019 | 594.44% | Chardan Capital | → $22.5 | Initiates Coverage On | → Buy |
| 10/29/2018 | 517.28% | Barclays | → $20 | Initiates Coverage On | → Overweight |
| 10/29/2018 | 332.1% | B of A Securities | → $14 | Initiates Coverage On | → Buy |
| 10/29/2018 | 517.28% | Morgan Stanley | → $20 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 07/27/2023 | 23.46% | 瑞銀集團 | $15→$4 | 評級下調 | 購買→中性 |
| 07/25/2023 | - | 查爾丹資本 | 評級下調 | 購買→中性 | |
| 07/25/2023 | -38.27% | 巴克萊 | $5→$2 | 維護 | 體重不足 |
| 07/25/2023 | - | 摩根大通 | 評級下調 | 中性→減持 | |
| 07/24/2023 | -7.41% | 傑富瑞 | →$3 | 評級下調 | 購買→Hold |
| 07/24/2023 | 116.05% | 大寫一 | →$7 | 評級下調 | 超重→等重 |
| 04/04/2023 | 208.64% | 摩根大通 | $12→$10 | 維護 | 中性 |
| 2022年11月14日 | 177.78% | 摩根士丹利 | $12→$9 | 維護 | 等重 |
| 2022年11月10日 | 146.91% | 高盛 | $9→$8 | 維護 | 中性 |
| 2022年08月15日 | 270.37% | 摩根士丹利 | $10→$12 | 維護 | 等重 |
| 2022年08月10日 | 455.56% | 查爾丹資本 | $19→$18 | 維護 | 買 |
| 08/09/2022 | 362.96% | Truist證券 | $10→$15 | 維護 | 買 |
| 08/09/2022 | 177.78% | 高盛 | $5→$9 | 維護 | 中性 |
| 08/02/2022 | 85.19% | 花旗集團 | →$6 | 評級下調 | 中性→銷售 |
| 2022年05月24日 | 54.32% | 高盛 | $7→$5 | 維護 | 中性 |
| 2022/05/17 | 208.64% | 摩根士丹利 | $12→$10 | 維護 | 等重 |
| 2022年05月11日 | 116.05% | 高盛 | $8→$7 | 維護 | 中性 |
| 04/12/2022 | 270.37% | 摩根士丹利 | $17→$12 | 維護 | 等重 |
| 02/24/2022 | 424.69% | 摩根士丹利 | $77→$17 | 維護 | 等重 |
| 02/24/2022 | 270.37% | 花旗集團 | $70→$12 | 維護 | 中性 |
| 02/24/2022 | 548.15% | 摩根大通 | $90→$21 | 評級下調 | 超重→中性 |
| 02/07/2022 | 1443.21% | 巴克萊 | $81→$50 | 維護 | 體重不足 |
| 02/02/2022 | 2677.78% | 摩根大通 | →$90 | 升級 | 中性→超重 |
| 02/01/2022 | 2276.54% | 摩根士丹利 | $122→$77 | 維護 | 等重 |
| 2022年01月26日 | 2060.49% | 花旗集團 | $114→$70 | 維護 | 中性 |
| 01/18/2022 | 3665.43% | 摩根士丹利 | $119→$122 | 維護 | 等重 |
| 2021年11月11日 | 3418.52% | 花旗集團 | $103→$114 | 維護 | 中性 |
| 2021/11/05 | 2554.32% | 巴克萊 | $90→$86 | 維護 | 體重不足 |
| 2021/11/05 | 3109.88% | 蒙特利爾銀行資本 | $138→$104 | 維護 | 市場表現 |
| 2021/11/05 | 4498.77% | 羅斯資本 | $155→$149 | 升級 | 中性→購買 |
| 05/04/2021 | 4437.04% | Truist證券 | $89→$147 | 維護 | 買 |
| 04/19/2021 | 3572.84% | 摩根士丹利 | $133→$119 | 維護 | 等重 |
| 03/12/2021 | - | Evercore ISI集團 | 開始承保 | →跑贏大盤 | |
| 03/08/2021 | 4004.94% | 摩根士丹利 | $125→$133 | 維護 | 等重 |
| 03/01/2021 | 2677.78% | 巴克萊 | $52→$90 | 評級下調 | 等重→減碼 |
| 02/17/2021 | 4683.95% | 羅斯資本 | $133→$155 | 評級下調 | 購買→中性 |
| 2021/01/25 | 4467.9% | 蒙特利爾銀行資本 | $145→$148 | 評級下調 | 跑贏→市場表現 |
| 12/17/2020 | 4714.81% | 貝倫伯格 | →$156 | 開始承保 | →購買 |
| 12/11/2020 | 4035.8% | 花旗集團 | →$134 | 開始承保 | →中性 |
| 11/30/2020 | 3758.02% | 摩根大通 | →$125 | 評級下調 | 超重→中性 |
| 11/16/2020 | 3758.02% | 摩根士丹利 | →$125 | 評級下調 | 超重→等重 |
| 11/13/2020 | 3140.74% | 高盛 | →$105 | 評級下調 | 購買→中性 |
| 11/10/2020 | 4004.94% | 羅斯資本 | $124→$133 | 維護 | 買 |
| 07/28/2020 | 2646.91% | SunTrust Robinson Humphrey | $90→$89 | 維護 | 買 |
| 2020/05/14 | 2677.78% | SunTrust Robinson Humphrey | $101→$90 | 維護 | 買 |
| 04/15/2020 | 2369.14% | 摩根士丹利 | $82→$80 | 維護 | 超重 |
| 03/31/2020 | 2183.95% | 蒙特利爾銀行資本 | →$74 | 開始承保 | →跑贏大盤 |
| 03/03/2020 | 2369.14% | 高盛 | →$80 | 開始承保 | →購買 |
| 02/18/2020 | 2029.63% | 巴克萊 | →$69 | 評級下調 | 超重→等重 |
| 02/06/2020 | 3017.28% | SunTrust Robinson Humphrey | →$101 | 開始承保 | →購買 |
| 1/03/2020 | 2986.42% | HC Wainwright公司 | →$100 | 開始承保 | →購買 |
| 2019年12月24日 | 2430.86% | 摩根大通 | →$82 | 開始承保 | →超重 |
| 2019年12月17日 | 2430.86% | 摩根士丹利 | $33→$82 | 維護 | 超重 |
| 2019年02月20日 | 594.44% | 查爾丹資本 | →$22.5 | 開始承保 | →購買 |
| 2018年10月29日 | 517.28% | 巴克萊 | →$20 | 開始承保 | →超重 |
| 2018年10月29日 | 332.1% | B of A證券 | →$14 | 開始承保 | →購買 |
| 2018年10月29日 | 517.28% | 摩根士丹利 | →$20 | 開始承保 | →超重 |
What is the target price for Kodiak Sciences (KOD)?
科迪亞克科學公司(KOD)的目標價格是多少？
The latest price target for Kodiak Sciences (NASDAQ: KOD) was reported by UBS on July 27, 2023. The analyst firm set a price target for $4.00 expecting KOD to rise to within 12 months (a possible 23.46% upside). 14 analyst firms have reported ratings in the last year.
瑞銀於2023年7月27日報道了科迪亞克科學公司(納斯達克：KOD)的最新目標價。這家分析公司將目標價定為4.00美元，預計KOD將在12個月內升至(可能上漲23.46%)。過去一年，有14家分析公司公佈了評級。
What is the most recent analyst rating for Kodiak Sciences (KOD)?
科迪亞克科學公司(KOD)的最新分析師評級是多少？
The latest analyst rating for Kodiak Sciences (NASDAQ: KOD) was provided by UBS, and Kodiak Sciences downgraded their neutral rating.
瑞銀提供了對科迪亞克科學公司(納斯達克代碼：KOD)的最新分析師評級，科迪亞克科學公司下調了其中性評級。
When is the next analyst rating going to be posted or updated for Kodiak Sciences (KOD)?
科迪亞克科學公司(KOD)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kodiak Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kodiak Sciences was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與科迪亞克科學公司的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Kodiak Sciences的上一次評級是在2023年7月27日提交的，因此您應該預計下一次評級將在2024年7月27日左右提供。
Is the Analyst Rating Kodiak Sciences (KOD) correct?
分析師對科迪亞克科學公司(KOD)的評級正確嗎？
While ratings are subjective and will change, the latest Kodiak Sciences (KOD) rating was a downgraded with a price target of $15.00 to $4.00. The current price Kodiak Sciences (KOD) is trading at is $3.24, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但科迪亞克科學公司(KOD)的最新評級被下調，目標價為15.00美元至4.00美元。科迪亞克科學公司(Kodiak Sciences)目前的股價為3.24美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
投資課程
看財報揀好股
快速掌握財報季學習指引
財報季來臨，公司股價最易大升大跌，很多優秀的投資者會將財報季視為“大賺一筆”的好時機。 假設你現在持有某隻股票，該公司發佈財報後股價跳水，大跌10%，此時你會怎麼做？ 短期波動不改長期增長邏輯，堅定持有 財報業績不及預期，馬上賣掉止盈止損 未來可能還要跌，賣掉之後反手做空 具體如何選擇？取決於我們是什麼類型的投資者，也
【2025.2】英偉達業績怎麼看？短線股價重點看這個指標
英偉達是近兩年美股中漲勢最好的科技巨頭之一，2024年以來股價更是經歷了顯著的增長，漲幅一度超過了兩倍。這樣的股價表現，首先在一定程度上反映了市場對其AI晶片地位的認可，還有對其前景的期待。 不過在今年1月底，受到DeepSeek低成本AI模型的衝擊，市場擔憂競爭格局發生變化，擔憂AI硬件的投資回報率會受影響，加上整體
【2025.1】特斯拉業績怎麽看？關註這四個重點
又到了美股業績期。而巨頭公司的業績，不但會影響自己的股價，甚至還會影響整個美股市場的走勢，其中也可能蘊含著交易機會。 那麼，這些巨頭公司的業績該怎麼看呢？今天我們聚焦特斯拉，看看特斯拉的業績有哪些關鍵因素，可能會對股價帶來什麼明顯影響…… 1、銷量變化 首先，對新能源車企來說，最重要的觀察指標始終是總交付量， 或者說銷